Evidence map›Paper›PMID 33843573›Full record

ArticleMicrobial genomics2021

Genome-wide analysis in

Jordy P M Coolen, Evert P M den Drijver, Jaco J Verweij, Jodie A Schildkraut, Kornelia Neveling, Willem J G Melchers, Eva Kolwijck, Heiman F L Wertheim, Jan A J W Kluytmans, Martijn A Huynen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Class C β-Lactamases: Molecular Characteristics.Clinical microbiology reviews · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jordy P M CoolenDepartment of Medical Microbiology and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Evert P M den DrijverDepartment of Infection Control, Amphia Ziekenhuis, Breda, The Netherlands.
Jaco J VerweijLaboratory for Medical Microbiology and Immunology, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands.
Jodie A SchildkrautDepartment of Medical Microbiology and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Kornelia NevelingDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Willem J G MelchersDepartment of Medical Microbiology and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Eva KolwijckDepartment of Medical Microbiology and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Heiman F L WertheimDepartment of Medical Microbiology and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Jan A J W KluytmansDepartment of Infection Control, Amphia Ziekenhuis, Breda, The Netherlands.
Martijn A HuynenCentre for Molecular and Biomolecular Informatics, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Nijmegen · NLAmphia Ziekenhuis · NLElisabeth-TweeSteden Ziekenhuis · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cefotaxime (CTX) is a third-generation cephalosporin (3GC) commonly used to treat infections caused by

Indexed as

Drug Resistance, BacterialGenome, BacterialHeteroplasmyAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCefotaximeEscherichia coliEscherichia coli InfectionsHumansMicrobial Sensitivity TestsMutationPlasmidsPromoter Regions, GeneticAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCefotaximeampCbioinformaticsEscherichia coligenomicswhole-genome sequencing

Identifiers

PMID33843573
PMCPMC8208684
OpenAlexW3156911673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.